NCT00750802View on ClinicalTrials.gov

A Sedation/Cognition/EEG Study Using AZD6280 and Comparator

PHASE1CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

September 30, 2008

Study Completion Date

December 31, 2008

Conditions

Healthy Volunteer

Interventions

DRUG

AZD6280

10mg Capsule, oral, single-dose

DRUG

AZD6280

40mg Capsule, oral, single-dose

DRUG

Lorazepam

2mg tablet, oral single-dose

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Leiden

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY